Entering text into the input field will update the search result below

Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steve Hoerter on Q2 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET

Company Participants

Jen Robinson - Vice President, Investor Relations

Steve Hoerter - President and Chief Executive Officer

Dan Martin - Chief Commercial Officer

Matt Sherman - Chief Medical Officer

Tucker Kelly - Chief Financial Officer

Conference Call Participants

Daniel Wolle - JPMorgan

Chris Raymond - Piper Sandler

Eun Yang - Jefferies

Charles Zhu - Guggenheim Securities

Srikripa Devarakonda - Truist Securities

Reni Benjamin - JMP Securities

Peter Lawson - Barclays

Arlinda Lee - Canaccord


Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals Second Quarter 2021 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Jen Robinson, Vice President of Investor Relations, Jen?

Jen Robinson

Thank you operator. Welcome, and thank you for joining us today to discuss Deciphera second quarter 2021 financial results. I am Jen Robinson, Vice President, Investor Relations at Deciphera. With me this afternoon to discuss the financial results and provide a general corporate update are Steve Hoerter, President and Chief Executive Officer; Dan Martin, Chief Commercial Officer; Matt Sherman, Chief Medical Officer; and Tucker Kelly, Chief Financial Officer.

Before we begin, I would like to remind you that any statements we make on this call that are not historical facts are forward-looking statements reflecting the current beliefs and expectations of management, made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements made during this conference call include our expectations for our preclinical and clinical programs, our commercialization of QINLOCK and 2021 guidance. Forward-looking statements made on this call involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we cannot

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.